Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2012

Sep 17, 2012

34807_dirs_2012-09-17_5ed240cd-ed9e-42e6-8bd8-12529402dec1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2012-09-12

Reporting Person: COLONNESE MARK P (Chief Financial Officer)